US EditionEuropean Commission Approves SYD-101 Low-Dose Atropine for Paediatric Myopia Treatment Across EU
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
European Commission Approves SYD-101 Low-Dose Atropine for Paediatric Myopia Treatment Across EU
The European Commission has approved marketing authoris […] The post European Commission Approves SYD-101 Low-Dose Atropine for Paediatric Myopia Treatment Across EU first appeared on GeneOnline News. The post European Commission Approves SYD-101 Low-Dose Atropine for Paediatric Myopia Treatment Across EU appeared first on GeneOnline News.
The intensive use of mobile phones, computers and tablets forces the eyes to maintain a constant effort, which prevents them from resting properly. The current lifestyle, marked by the abuse of screens from younger and younger ages, is generating a phenomenon called “accommodative spasm”, a visual disorder that, if not detected and slowed down in time, can seriously affect the eye health of the population in the coming years. Ophthalmologists wa…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
